Show simple item record

dc.contributor.authorSaglam, Esra Kaytan
dc.contributor.authorSanli, Yasemin
dc.contributor.authorYilmaz, Ebru
dc.contributor.authorKuyumcu, Serkan
dc.contributor.authorVatankulu, Betül
dc.contributor.authorPurisa, Sevim
dc.contributor.authorAdalet, Isik
dc.contributor.authorOzkan, Zeynep Gozde
dc.date.accessioned2021-03-03T13:55:26Z
dc.date.available2021-03-03T13:55:26Z
dc.date.issued2015
dc.identifier.citationVatankulu B., Sanli Y., Saglam E. K. , Kuyumcu S., Ozkan Z. G. , Yilmaz E., Purisa S., Adalet I., "Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?", MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.24, sa.3, ss.120-127, 2015
dc.identifier.othervv_1032021
dc.identifier.otherav_36d7d388-5e06-4345-ad09-c35243af28fa
dc.identifier.urihttp://hdl.handle.net/20.500.12627/41000
dc.identifier.urihttps://doi.org/10.4274/mirt.36744
dc.description.abstractObjective: We aimed to investigate the SUVmax of primary tumor and metastatic lymph node in predicting survival in patients with esophageal cancer.
dc.language.isoeng
dc.subjectTıp
dc.subjectNükleer Tıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleDoes Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?
dc.typeMakale
dc.relation.journalMOLECULAR IMAGING AND RADIONUCLIDE THERAPY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume24
dc.identifier.issue3
dc.identifier.startpage120
dc.identifier.endpage127
dc.contributor.firstauthorID102245


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record